ResearcherKanazawa Medical UniversityNo recent work listed

Naohisa Tomosugi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9328-8116; OpenAlex author ID A5016190886. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2012: 2 papers

Papers 2

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. Co-author DOI 10.1007/s00535-011-0484-9 ↗
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro. Last author DOI 10.3892/or.2012.2020 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshiharu Motoo · 2 shared papers, 2012 · strength 0.06
- Paper Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro. DOI 10.3892/or.2012.2020 ↗
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9 ↗
Takanobu Takata · 2 shared papers, 2012 · strength 0.06
- Paper Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro. DOI 10.3892/or.2012.2020 ↗
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9 ↗
Takeo Shimasaki · 2 shared papers, 2012 · strength 0.06
- Paper Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro. DOI 10.3892/or.2012.2020 ↗
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9 ↗
Ayako Kitano · 1 shared paper, 2012 · strength 0.03
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9 ↗
Toshinari Minamoto Md · 1 shared paper, 2012 · strength 0.03
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.